Octapharma AG Announces First-Ever Research Grants Program, Demonstrating Commitment to Cutting-Edge Clinical Research  
3/30/2009 10:34:29 AM

LACHEN, Switzerland & HOBOKEN, N.J.--(BUSINESS WIRE)--Octapharma AG, one of the world’s largest plasma products manufacturers, is celebrating its 25th anniversary by demonstrating its commitment to cutting-edge clinical research with the launch of the Octapharma 25th Anniversary Grants Program. The company’s first ever grants program is only available to researchers based in the United States and will be administered exclusively by Octapharma USA, the Swiss company’s rapidly-growing U.S. subsidiary.